CBR1 anticorps (AA 1-277)

N° du produit ABIN5775915

Cet anticorps Souris Monoclonal détecte spécifiquement CBR1 dans WB, ELISA, ICC et IF. Il présente une réactivité envers Humain.

Aperçu rapide pour CBR1 anticorps (AA 1-277) (ABIN5775915)

Antigène: CBR1 (Carbonyl Reductase 1 (CBR1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CBR1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)

Clone: AT4E12

Détail du produit anti-CBR1 anticorps

Épitope: AA 1-277

Immunogène: Recombinant human CBR1 (1-277 aa ) purified from E. coli

Isotype: IgG2a kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.

Détails sur CBR1

Antigène: CBR1 (Carbonyl Reductase 1 (CBR1))

Autre désignation: Carbonyl reductase 1/CBR1

Sujet: Carbonyl reductase 1 (CBR1) is a NADPH-dependent, monomeric, and cytosolic enzyme belonging to a family of short-chain dehydrogenases/reductases. This protein consists of 277 amino acid residues and is widely distributed in human tissues such as liver, epidermis, stomach, small intestine, kidney, neuronal cells, and smooth muscle fiber. CBR1 metabolizes many toxic environmental quinones and pharmacological relevant substrates such as the anticancer drug, doxorubicin. The best substrates of CBR1 are quinones, including ubiquinone-1 and tocophrolquinone (vitamin E).

NCBI Accession: NP_001748